Neuropace Inc NPCE

US Health Care

$12.89 ▼ -6.25% ($-0.86)

⬇️ Below Yest. Low 🗓️ Earnings Next Week

Open $13.74

Prev Close $13.75

Day Range $12.66 – $13.74

52W Range $7.56 – $19.60

Market Cap $439.47M

Beta 1.97

EPS (TTM) $-0.65

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2021-04-22
Shares Out.	34,090,000
Website	neuropace.com/ ↗
Phone	16502372700
Employees	220
Revenue	$22.1M
Gross Profit	$18.0M
Net Income	-$6.7M
Free Cash Flow	-$9.8M
Total Assets	$98.9M
Total Liabilities	$84.4M
Equity	$14.5M

About Neuropace Inc

NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.

Neuropace Inc is a publicly traded company under the ticker symbol NPCE on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.